Maze Therapeutics Statistics
NASDAQ: MAZEHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
26.25-0.18 (-0.68%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Maze Therapeutics by the numbers
Maze Therapeutics has a market capitalization of $1.46 billion based on 55.55M shares outstanding. With trailing EPS of $-2.48, Maze Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 2.5% below its 50-day average and 20.1% below its 200-day average.
Average daily trading volume is 556.08K shares, or about $14.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
MAZE valuation vs. peer median
| Metric | MAZE | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.46B | $1.36B | +7% |
| Avg. volume | 556.08K | 522.50K | +6% |
Peer median across 8 companies: TSHA, IMCR, INBX, COAG, REPL, IMTX, MESO, VOR.
Valuation
- Market cap
- $1.46B
- EPS (TTM)
- $-2.48
- Shares outstanding
- 55.55M
Price and trading
- Previous close
- 26.43
- Open
- 26.30
- Day range
- 25.87 – 26.89
- 52-week range
- 21.95 – 53.65
- 52-week change
- -5.78%
- Beta
- —
- Volume
- 823.90K
- Average volume
- 556.08K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 1.46B
- Forward Pe
- -8.14
- Eps
- -2.48
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 53.65
- Week52 Low
- 21.95
- Avg Volume
- 556.08K
- Shares Outstanding
- 55.55M
- Ma50
- 26.93
- Ma200
- 32.86
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -51.07%
- Pct From52w Low
- 19.59%